Treatment of type 2 diabetes mellitus

Hospital Pharmacist

Volumn 8, Issue 1, 2001, Pages 10-16

  Bhattacharyya, A ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; BIGUANIDE DERIVATIVE; CHLORPROPAMIDE; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; GLIQUIDONE; METFORMIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

BLOOD GLUCOSE MONITORING; DIABETES CONTROL; DIET THERAPY; DIETARY INTAKE; EXERCISE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MEDICAL DECISION MAKING; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS TRANSPLANTATION; REVIEW;

EID: 0035139048     PISSN: 13527967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Diabetes ketoacidosis in non-insulin dependent diabetes mellitus
2. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial
3. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
4. Importance of control of type 2 diabetes mellitus
5. Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin epidemiologic study of diabetic retinopathy
6. Diabetic control and progression of retinopathy in elderly patients: Five-year follow up study
7. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with noninsulin-dependent diabetes mellitus: A randomised prospective 6-year study
8. Long-term glycaemic control related to mortality in type 2 DM
9. Diabetes "tight control" in a comprehensive treatment plan
10. Weight control: Metabolic and cardiovascular effects
11. Exercise and NIDDM
12. Effects of hypoglycaemic agents on vascular complications in patients with diabetes: 2. Mortality results
13. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
14. An overview of metformin in the treatment of type 2 DM
15. Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes
16. Troglitazone
17. A comparison in a clinical setting of the efficacy and side effects of three thiazolinediones
18. Life-threatening hypoglycaemia in a patient with type I diabetes mellitus
19. Use of insulin aspart, a fast-acting insulin analogue, as the meal time insulin in the management of patients with type I diabetes
20. Pancreas transplants for United States (US) and non-US cases reported to the International Pancreas Transplant Registry and to the United Network for Organ Sharing (UNOS)
21. Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropyl cyclohexanecarbonyl)-D-phenylalanine (A-4166)
22. Improved control of mealtime glucose excursion with co-administration of nateglinide and metformin
23. New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycaemic properties
24. Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes
25. Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX- 1, in insulinoma cells
26. Continuous subcutaneous infusion of glucagon-like peptide-1 lowers plasma glucose and reduces appetite in type 2 diabetic patients
27. Less hypoglycaemia with insulin glargine in intensive insulin therapy for type 1 diabetes
28. Time-action profile of the long-acting insulin analogue insulin glargine (HOE 901) in comparison with those of NPH insulin and placebo
29. Novel hepatoselective insulin analogue
30. Prospective randomised study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus
31. DIGAMI in a district general hospital in the UK: Influence, implementation and outcome
32. Possible foetal effect of insulin lispro
33. Lispro and regular insulin in pregnancy: A comparison
34. Insulin lispro, pregnancy and retinopathy
35. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)